These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28280785)

  • 1. Cost-Effectiveness Analysis of Quadripolar Versus Bipolar Left Ventricular Leads for Cardiac Resynchronization Defibrillator Therapy in a Large, Multicenter UK Registry.
    Behar JM; Chin HM; Fearn S; Ormerod JO; Gamble J; Foley PW; Bostock J; Claridge S; Jackson T; Sohal M; Antoniadis AP; Razavi R; Betts TR; Herring N; Rinaldi CA
    JACC Clin Electrophysiol; 2017 Feb; 3(2):107-116. PubMed ID: 28280785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Resynchronization Therapy Delivered Via a Multipolar Left Ventricular Lead is Associated with Reduced Mortality and Elimination of Phrenic Nerve Stimulation: Long-Term Follow-Up from a Multicenter Registry.
    Behar JM; Bostock J; Zhu Li AP; Chin HM; Jubb S; Lent E; Gamble J; Foley PW; Betts TR; Rinaldi CA; Herring N
    J Cardiovasc Electrophysiol; 2015 May; 26(5):540-6. PubMed ID: 25631303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalization rates and associated cost analysis of cardiac resynchronization therapy with an implantable defibrillator and quadripolar vs. bipolar left ventricular leads: a comparative effectiveness study.
    Forleo GB; Di Biase L; Bharmi R; Dalal N; Panattoni G; Pollastrelli A; Tesauro M; Santini L; Natale A; Romeo F
    Europace; 2015 Jan; 17(1):101-7. PubMed ID: 25371428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a risk-stratified approach to cardiac resynchronisation therapy defibrillators (high versus low) at the time of generator change.
    Claridge S; Sebag FA; Fearn S; Behar JM; Porter B; Jackson T; Sieniewicz B; Gould J; Webb J; Chen Z; O'Neill M; Gill J; Leclercq C; Rinaldi CA
    Heart; 2018 Mar; 104(5):416-422. PubMed ID: 28970277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2017 Mar; 5(3):204-212. PubMed ID: 28254126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
    Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
    Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of quadripolar LV leads on heart failure hospitalization rates among patients implanted with CRT-D: data from the Israeli ICD Registry.
    Leshem E; Suleiman M; Laish-Farkash A; Haim M; Geist M; Luria D; Glikson M; Goldenberg I; Michowitz Y;
    J Interv Card Electrophysiol; 2018 Jan; 51(1):5-12. PubMed ID: 29274032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact on the incidence of postoperative ventricular arrhythmias after cardiac resynchronization therapy defibrillator with quadripolar lead].
    Wu GH; Chen KY; Yu F; Wang Q; Xu J; Su H; Yang DM; Yan J
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3548-3552. PubMed ID: 29275593
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure.
    Woo CY; Strandberg EJ; Schmiegelow MD; Pitt AL; Hlatky MA; Owens DK; Goldhaber-Fiebert JD
    Ann Intern Med; 2015 Sep; 163(6):417-26. PubMed ID: 26301323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study.
    Forleo GB; Di Biase L; Panattoni G; Mantica M; Parisi Q; Martino A; Pappalardo A; Sergi D; Tesauro M; Papavasileiou LP; Santini L; Calò L; Tondo C; Natale A; Romeo F
    J Interv Card Electrophysiol; 2015 Jan; 42(1):59-66. PubMed ID: 25504267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and Reliability of Selected Site Pacing for Avoidance of Phrenic Nerve Stimulation in CRT Patients with Quadripolar LV Leads: The EffaceQ Study.
    Oswald H; Asbach S; Köbe J; Weglage H; Schulte-Pitzke B; Brachmann J
    Pacing Clin Electrophysiol; 2015 Aug; 38(8):942-50. PubMed ID: 25974406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure.
    Mealing S; Woods B; Hawkins N; Cowie MR; Plummer CJ; Abraham WT; Beshai JF; Klein H; Sculpher M
    Heart; 2016 Nov; 102(21):1742-1749. PubMed ID: 27411837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Considerations of Cardiovascular Implantable Electronic Devices for The Treatment of Heart Failure.
    Elsner C; Bettin S; Tilz R; Häckl D
    Curr Heart Fail Rep; 2024 Jun; 21(3):186-193. PubMed ID: 38662154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of a novel left ventricular lead with short bipolar spacing for cardiac resynchronization therapy: primary results of the Attain Performa quadripolar left ventricular lead study.
    Crossley GH; Biffi M; Johnson B; Lin A; Gras D; Hussin A; Cuffio A; Collier JL; El-Chami M; Li S; Holloman K; Exner DV
    Heart Rhythm; 2015 Apr; 12(4):751-8. PubMed ID: 25533587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
    Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
    Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.